VCM
MRNA icon

Voleon Capital Management’s Moderna MRNA Stock Holding History

Voleon Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$295K Sell
4,215
-8,966
-68% -$464K 0.01% 686
2026
Q1 		$670K Sell
13,181
-8,828
-40% -$412K 0.01% 518
2025
Q4 		$649K Buy
22,009
+11,891
+118% +$323K 0.01% 524
2025
Q3 		$261K Buy
+10,118
New +$282K 0.01% 762
2025
Q2 		– Sell
-42,507
Closed -$1.21M – 509
2025
Q1 		$1.21M Buy
+42,507
New +$1.51M 0.09% 180

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Voleon Capital Management's MRNA Position: Q2 2026 in Review

Voleon Capital Management reduced its Moderna (MRNA) stake by 68% in Q2 2026, selling an estimated $464K and leaving 4,215 shares worth $295K. The position accounts for 0.01% of the portfolio, ranked #686.

Voleon Capital Management first reported a position in MRNA in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.21M in Q1 2025. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Voleon Capital Management held 4,215 shares of Moderna worth $295K as of Q2 2026.
  • Voleon Capital Management sold 8,966 Moderna shares in Q2 2026, an estimated $464K.
  • Moderna made up 0.01% of Voleon Capital Management's portfolio in Q2 2026, its #686 holding.
  • Voleon Capital Management first reported a position in Moderna in Q1 2025 and has held it in 5 quarters since.
  • Voleon Capital Management's Moderna position peaked at $1.21M in Q1 2025.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.